Agenus raises up to $340M to fund MSS colon cancer Phase 3 trial
Go back to Agenus raises up to $340M to fund MSS colon cancer Phase 3 trial| AGENUS (NASDAQ: AGEN) | Delayed: 7.72 -0.52 (6.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.24 | 52 Week High | $7.49 | |||
| Open | $8.14 | 52 Week Low | $2.61 | |||
| Day High | $8.18 | P/E | N/A | |||
| Day Low | $7.68 | EPS | $-1.10 | |||
| Volume | 611,755 | |||||
